Full Year 2021 SanBio Co Ltd Earnings Call Transcript

Mar 17, 2021 / NTS GMT
Keita Mori - SanBio Company Limited - Co-Founder, President, Executive Officer & Representative Director

Hello. This is Keita Mori from SanBio. We are now going to start the financial results update for the fiscal year ending January 31, 2021. First, actually, we just reached our 20th anniversary last month, February of this year. From 20 years ago, we have been trying to create new categories of medicine, and all of us at SanBio has been working hard and diligently to fulfill this goal. It feels like the time has passed very quickly as we have been working in this mission. Today is the first meeting since the 20th anniversary, and we are delighted to provide the snapshot of where we are as of today.

As usual, I'd like to provide updates on the financial results. First, income statement. Our operating expense were in line with the previous year, as you can see. And operating expense are staying at around $55 million, $60 million equivalent this year as well. I'd like to just highlight that this year, we have sold our holdings of our investment securities, namely CareNet, and that -- due to this,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot